Managing the 3 Fronts of the Drug Pricing

In this ISSUE

Mapping Out the Future of Cell and Gene Therapy

Will AI Kill Pharma Rep Jobs?

Gene Therapy: How 'Advanced' is Europe?

Opinion

Europe's Troubled Autumn Could Be Bad News for Pharma

As well as official European projections of sharply slowing industry growth and geopolitical concerns, pharma executives face additional hazards as they plot their medium-term strategies, writes Reflector.
... /Read more/

Launching Medical Devices in the Japanese Market - How to navigate regulatory and reimbursement approval
Thursday, October 31, 2019 at 11am EDT

Regulatory Affairs

"Sunshine" on Marketing, Research Payments Expands at Home and Abroad

As part of the legislation expanding the federal Open Payments program, drug and medical device manufacturers will have to report payments and other "transfers of value" to a broader range of health professionals.
... /Read more/

Managing Global Regulatory Complexity: Clinical Trial Transparency, Reporting and Real-time Data Driven Compliance
On Demand

Learn More

Drug Pricing

Managing the Three Fronts of the Drug Pricing Conundrum: Policy, Creativity, Collaboration

The impacts of disruptive curative therapies and advances in the future of health will be profound. To be best positioned for success, healthcare systems under continuous cost pressure must address three key areas, writes Thomas Unger.
... /Read more/

Calendar

/ 17th Annual Independent Medical Education and Grants Summit – 9/16–9/17 /

/ American Pharma Outsourcing Summit – 9/23–9/24 /

/ 13th Hub and SPP Model Optimization – 9/26–9/27 /

/ 116th Annual Patient Summit USA – 10/2-10/3 /

Letter from the Editor

A Look Back & Forward on Innovation

In a sit-down with editors from our group publications, former FDA Commissioner Scott Gottlieb chatted with Pharm Exec on several topics, including the evolution of pricing and reimbursement for novel therapies—and the access fixes needed for future.
... /Read more/

The Pharm Exec Podcast: Episode 39

Sponsored by Fingerpaint

CEO Builds Business With Compassion

Apellis' CEO and co-founder, Dr. Cedric Francois talks with Pharm Exec editors about his journey from clinical work to creating biotech startups, which has included research, clinical work, and the launch of two startups.
... /Read more/

update my profile / advertise with us / print & digital subscribe / visit pharmexec.com